Abstract
The purpose of the study was to examine the effect of ketotifen on the airway responses and the recruitment of the inflammatory cells into the airways of sensitized rats after antigen challenge. Twenty-five Brown Norway rats, 7–9 weeks old, were actively sensitized to ovalbumin (OA) (1 mg s.c.) andBordetella pertussis vaccine (109 bacilli i.p.) At 14 days after sensitization rats were anesthetized with urethane (1.1 g/kg i.p.) and intubated endotracheally. Aerosols of OA (5% W/V in saline for 5 min) were administered to control rats (Group A;n=9), to a low-dose ketotifen group (Group B; 1 mg/kg PO;n=8) and a high-dose ketotifen group (Group C; 10 mg/kg; PO for 10 days;n=9). Pulmonary resistance (R L) was measured at baseline, and every 15 min for up to 8 h after OA. The magnitude of the early response was 241±51% in A (% baselineR L; mean±SE), and significantly less in B (119±7%) and C (131±16%) (p<0.01). The late response was significantly lower in C than A but not B. The total cell number in bronchoalveolar lavage at 8 h after OA challenge was significantly higher in A than B and C (p<0.01). The lymphocyte and eosinophil counts were reduced in B and C compared to A (p<0.05). A positive correlation was found between the late response and total number of cells recovered in the BAL (r=0.78) (p<0.05). We conclude that ketotifen inhibited the early response and late response, and the influx of inflammatory cells into the airways after antigen challenge.
Similar content being viewed by others
References
M. Kaliner,Asthma and mast cell activation. J. Allergy Clin. Immunol.83, 510–520 (1989).
D. W. Cockcroft, R. E. Ruffin, J. Dolovich and F. E. Hargreave,Allergen-induced increase in non-allergic bronchial reactivity. Allergy7, 503–513 (1977).
M. P. Shampain, B. L. Behrens, G. L. Larsen and P. M. Henson,An animal model of late pulmonary response to alternaria challenge. Am. Rev. Respir. Dis.126, 493–498 (1982).
W. M. Abraham, J. C. Delehunt, L. Yerger and B. Marchette,Characterization of a late phase pulmonary response following antigen challenge in allergic sheep. Am. Rev. Respir. Dis.128, 839–844 (1983).
H. Iijima, M. Ishii, K. Yamauchi, et al.,Bronchoalveolar lavage and histological characterization of late asthmatic response in guinea pigs. Am. Rev. Respir. Dis.136, 922–929 (1987).
R. Hamel, C. S. McFarlane and A. W. Ford-Hutchinson,Late pulmonary responses induced by Ascaris allergen in conscious squirrel monkeys. J. Appl. Physiol.61, 2081–2087 (1986).
R. Pauwels, H. Bazin, B. Plateau and M. Van der Straeten,The influence of antigen dose on IgE production in different rat strains. Immunology36, 151–157 (1979).
D. H. Eidelman, S. Bellofiore and J. G. Martin,Late airway responses to antigen challenge in sensitized inbred rats. Am. Rev. Respir. Dis.137, 1033–1037 (1988).
L. P. Craps and U. M. Ney,Ketotifen: Current views on its mechanism of action and their therapeutic implications. Respiration45, 411–421 (1984).
U. Martin and M. Baggiolini,Dissociation between the anti-anaphylactic and the anti-histaminic actions of ketotifen. Naunyn-Schmiedeberg's Arch. Pharmacol.316, 186–189 (1981).
M. Adachi, H. Kobayashi, N. Aoki, M. Iijima, F. Kokuby, A. Furuya and T. Takahashi,A comparison of the inhibitory effects of ketotifen and disodium cromoglycate on bronchial responses to house dust, with special reference to the late asthmatic response. Pharmatherapeutica4, 36–42 (1984).
M. A. King, I. Chapman, A. Kristenssen, J. Sanjar and J. Morley,Human recombinant lymphokines and cytokines induce pulmonary eosinophilia in the guinea pig which is inhibited by ketotifen and AH 21-132. Arch. Allergy Appl. Immunol.91, 354–361 (1990).
S. Sapienza, D. H. Eidelman, P. M. Renzi and J. G. Martin,Role of leukotriene D4, in the early and late pulmonary responses of rats to allergen challenge. Am. Rev. Respir. Dis.142, 353–358 (1990).
U. Martin and D. Roemer,The pharmacological properties of a new orally active anti-anaphylactic compound: Ketotifen, a benzocycloheptajiophene. Drug Res.28, 770–786 (1978).
B. Wuethrich, P. Radielovic and M. Debelic,The protective effects of a new oral anti-asthma (ketotifen, HC20-511) against experimentally induced bronchospasm 5 different models. Int. J. Clin. Pharmacol.16, 424–429 (1978).
S. Esau, J. Del Carpio and J. G. Martin,A comparison of the effects of ketotifen and clemastine on cutaneous and airway reactivity to histamine and allergen in atopic asthmatic subjects. J. Allergy Clin. Immunol.74, 270–274 (1984).
D. P. Hutson, R. B. Bressler, M. Kaliner, L. K. Sowell and M. W. Baylor,Prevention of mast cell degranulation by ketotifen in patients with physical urticarias. Ann. Int. Med.104, 507–510 (1986).
L. E. Mansfield, P. Taistra, J. Snatamauro, S. King and K. Andriano,Inhibition of dermographia, histamine and dextromethorphan skin tests by ketotifen. A possible effect on cutaneous vascular response to mediators. Ann. Allergy63, 201–206 (1989).
H. Piechuta, A. W. Ford-Hutchinson and L. G. Letts,Inhibition of allergen-induced bronchoconstriction in hyperreactive rats as a model for testing 5-lipoxygenase inhibitors and leukotriene D 4 receptor antagonists. Agents and Actions22, 69–74 (1987).
J. G. R. De Monchy, H. F. Kaufman, P. Venge, et al.,Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis.131, 373–376 (1985).
W. M. Abraham, M. W. Sielczak, A. Wanner, et al.,Cellular markers of inflammation in the airways of allergic sheep with and without allergen induced late responses. Am. Rev. Respir. Dis.138, 1565–1571 (1988).
W. R. Marsh, C. G. Irvin, K. R. Murphy, B. L. Behrens and G. L. Larsen,Increases in airway reactivity to histamine and inflammatory cells in bronchoalveolar lavage after the late asthmatic response in an animal model. Am. Rev. Respir. Dis.131, 875–879 (1985).
S.T. Blythe, D. England, B. Esser, P. Junk and R. F. Lemanske,IgE antibody mediated inflammation of rat lung: histologic and bronchoalveolar lavage assessment. Am. Rev. Respir. Dis.134, 1246–1251 (1986).
P. A. Hutson, S. T. Holgate and M. K. Church,The effects of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of non-anesthetized guinea pigs. Am. Rev. Respir. Dis.138, 1157–1163 (1988).
J. C. Delehunt, A. P. Perruchoud, L. Yerger, B. Marchette, J. S. Stevenson and W. M. Abraham,The role of slowreacting substance of anaphylaxis in the late bronchial response after antigen challenge in allergic sheep. Am. Rev. Respir. Dis.130, 748–754 (1984).
M. Joseph and A. Capron,IgE receptors on macrophages: Biological significance. Agents and Action16, 27–29 (1985).
J. a. Rankin, W. Hitchcock, M. K. Merrill, M. K. Bach, J. R. Brashler and P. W. Askenase,IgE dependent release of leukotriene C4 from alveolar macrophages. Nature (London)297, 329–331 (1982).
Y. Kakuta, T. Kaito, H. Sasaki and T. Takashima,Effect of ketotifen on human alveolar macrophages. J. Allergy Clin. Immunol.81, 469–474 (1988).
W. Podleski, B. A. Panaszek, J. L. Schmidt and R. B. Burns,Inhibition of eosinophils degranulation by ketotifen in a patient with milk allergy, manifested as bronchial asthma —an electronic microscopic study. Agents and Actions15, 177–181 (1984).
J. Morley, C. P. Page, L. Mazzoni and S. Sanjar,Effects of ketotifen upon responses to platelet activating factor: a basis for asthma prophylaxis. Ann. Allergy56, 335–340 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sapienza, S., Renzi, P.M. & Martin, J.G. Effects of ketotifen on airway responses to allergen challenge in the actively sensitized Brown Norway rat. Agents and Actions 37, 238–244 (1992). https://doi.org/10.1007/BF02028115
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02028115